New Insights in the Mobilization of Hematopoietic Stem Cells in Lymphoma and Multiple Myeloma Patients

New Insights in the Mobilization of Hematopoietic Stem Cells in Lymphoma and Multiple Myeloma Patients

Following chemotherapy and/or the administration of growth factors, such as granulocyte-colony stimulated factor (G-CSF), hematopoietic stem cells (HSC) mobilize from bone marrow to peripheral blood. This review aims to systematically present the structure of the HSC “niche” and elucidate the mechan...

Full description

Bibliographic Details
Main Authors:	Maria K. Angelopoulou, Pantelis Tsirkinidis, Georgios Boutsikas, Theodoros P. Vassilakopoulos, Panayiotis Tsirigotis
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2014/835138

Similar Items

Effect of bortezomib on the efficiency of hematopoietic stem cell mobilization in patients with multiple myeloma
by: O S Pokrovskaia, et al.
Published: (2012-07-01)

Significance of the detection of paroxysmal nocturnal hemoglobinuria clones in patients with multiple myeloma undergoing autologous stem cell transplantation
by: Vasileios Chatziantoniou, et al.
Published: (2015-12-01)

Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma
by: Maiia V. Firsova, et al.
Published: (2021-07-01)

Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs
by: OV Pirogova, et al.
Published: (2018-04-01)

Mobilization potential of patients with lymphomas and multiple myeloma involved in autologous stem cell transplant
by: Stančev Katarina, et al.
Published: (2020-01-01)

The impact of multiple myeloma induction therapy on hematopoietic stem cell mobilization and collection: 25-year experience
by: Amarilis Figueiredo, et al.
Published: (2019-10-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-01-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-11-01)

New Insights into Monoclonal B-Cell Lymphocytosis
by: Christina Kalpadakis, et al.
Published: (2014-01-01)

Association of oxidative stress and DNA damage with grafting time in patients with multiple myeloma and lymphoma submitted to autologous hematopoietic stem cell transplantation
by: Thayna Nogueira dos Santos, et al.

Certain Aspects of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2017-01-01)

Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
by: S. A. Tuchman, et al.
Published: (2012-01-01)

Sequential, autologous hematopoietic stem cell transplant followed by renal transplant in multiple myeloma
by: D Bhowmik, et al.
Published: (2017-01-01)

Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple Myeloma
by: Rahul Naithani, et al.
Published: (2020-10-01)

Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies
by: Theodoros P. Vassilakopoulos, et al.
Published: (2020-02-01)

Hematopoietic Stem Cell Collection in Multiple Myeloma Patients: Influence of the Lenalidomide-Based Therapy and Mobilization Regimen Prior to Auto-HSCT
by: II Kostroma, et al.
Published: (2018-04-01)

Managing anemia in lymphoma and multiple myeloma
by: Gunnar Birgeg&aring;rd
Published: (2008-04-01)

Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020-12-01)

Hematopoietic stem cell transplantation in Multiple Myeloma. Experience of the Instituto Nacional de Cancerologia, Mexico
by: Cervera-Ceballos Eduardo, et al.
Published: (2007-02-01)

Circulating hematopoietic progenitors and CD34+ cells predicted successful hematopoietic stem cell harvest in myeloma and lymphoma patients: experiences from a single institution
by: Yu JT, et al.
Published: (2016-02-01)

Multiple myeloma in Saudi Arabia: Consensus of the Saudi lymphoma/myeloma group
by: Ahmed Alaskar, et al.
Published: (2019-01-01)

Management of central nervous system involvement in multiple myeloma after autologous hematopoietic stem cell transplantation
by: Khatereh Mousavi-Fatemi, et al.
Published: (2020-01-01)

Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients
by: A. S. Rosenberg, et al.
Published: (2021-01-01)

Concurrent Presentation of Hodgkin Lymphoma and Multiple Myeloma
by: Rekha Chandran, et al.
Published: (2013-01-01)

New Insights in Anti-Angiogenesis in Multiple Myeloma
by: Domenico Ribatti, et al.
Published: (2018-07-01)

Hematopoietic stem cell transplantation for the management of follicular lymphoma
by: Chitra Hosing
Published: (2010-05-01)

Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myeloma
by: Yao Chen, et al.
Published: (2019-08-01)

Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients
by: Prajakta Shinde, et al.
Published: (2019-05-01)

Multiple myeloma: Maintenance therapy after autologous hematopoietic stem cell transplantation, depending on minimal residual disease
by: M V Solovyev, et al.
Published: (2017-07-01)

Experience with the Use of Thio/Mel Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2019-05-01)

Efficacy and prognostic factors of autologous hematopoietic stem cell transplantation for multiple myeloma: clinical analysis of 53 cases
by: HE Renke, et al.
Published: (2021-03-01)

Mobilization with cyclophosphamide reduces the number of lymphocyte subpopulations in the leukapheresis product and delays their reconstitution after autologous hematopoietic stem cell transplantation in patients with multiple myeloma
by: Skerget Matevz, et al.
Published: (2016-12-01)

Plerixafor in non-Hodgkin’s lymphoma and multiple myeloma patients undergoing autologous stem cell transplantation
by: Jan S. Moreb
Published: (2011-10-01)

Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies
by: Theodoros P. Vassilakopoulos, et al.
Published: (2019-07-01)

Insights on Multiple Myeloma Treatment Strategies
by: María-Victoria Mateos, et al.
Published: (2019-02-01)

Radiological management of skeletal metastases, multiple myeloma and lymphoma
by: Maximilian F. Reiser
Published: (2002-12-01)

Bispecific antibodies for non-Hodgkin’s lymphomas and multiple myeloma
by: Omar Castaneda-Puglianini, et al.
Published: (2021-09-01)

Allogeneic Hematopoietic Transplantation for Multiple Myeloma in the New Drugs Era: A Platform to Cure
by: Alberto Mussetti, et al.
Published: (2020-10-01)

Hematopoietic stem cell mobilization for autologous transplantation in multiple myeloma patients previously exposed to cyclophosphamide, thalidomide, and dexamethasone: is granulocyte-colony stimulating factor alone enough?
by: Afonso Celso Vigorito

The illustration of the successful mobilization of hematopoietic stem cells using plerixafor and pegfilgrastim in the patient with non-hodgkin's lymphoma
by: M S Motalkina, et al.
Published: (2015-06-01)